Skip to main content
. 2022 Apr 12;2(3):294–308. doi: 10.1016/j.jacasi.2021.12.012

Figure 2.

Figure 2

Kaplan-Meier Curves for the Clinical Outcome Measures: Diabetes Versus Nondiabetes

Kaplan-Meier curves for (A) major adverse cardiovascular and cerebral endpoints, (B) all-cause death, (C) cardiovascular death, (D) noncardiovascular death, (E) myocardial infarction, (F) stroke, (G) target vessel revascularization, (H) any coronary revascularization, and (I) heart failure hospitalization. The Kaplan-Meier curves were truncated at 5 years.